The Cannabusiness Key
February 2 at 12:00 pm
Hosted by Offit Kurman and featuring Cannabis Practice Group attorneys and experts from outside the firm this monthly, hour-long webinar series addresses operational and legal issues affecting those in legalized cannabis industry. The series is designed for applicants for, and operators of, legal cannabis businesses as well as business owners and service providers servicing the industry. Sign up here to receive email invitations to The Cannabusiness Key in your inbox.
Medical Ethics and Patient Advisory in Your Cannabis Business
Friday, February 2nd
12:00 – 1:00 PM EST
Offit Kurman Cannabis Attorney, Jason Klein, will host Medical Ethics and Patient Advisory in Your Cannabis Business
The discussion will focus on:
- 4 Principles of medical ethics in relation to cannabis use;
- Brief history of medical ethics and use of cannabis;
- Cannabis, palliative care, and end of life;
- Cannabis for symptom and spiritual palliation;
- Pain management and Cannabinoid Integrative Medicine (CIM); and
- Challenges and ethical questions.
ABOUT THE GUEST SPEAKERS
Debra Kimless, M.D., is a board-certified Anesthesiologist and ForwardGro’s medical director, who consults pro bono with patients to help guide them with cannabis medicine treatment. Dr. Kimless is widely regarded by her peers as one of the most experienced physicians specializing in the endocannabinoid system (“ECS”), microdose, topical therapies, and how medical cannabis can be beneficial to help treat medical conditions as well as reduce or replace opioids for pain relief.
She is frequently invited to speak at industry leading conferences and symposiums regarding the use of medical cannabis, and shares her knowledge by consulting with patients in legal states pro bono, to introduce cannabis as a medicinal option. She has first-hand experience in successfully aiding patients with various medical conditions. She helps patients tailor their treatment plans by using different methods of administration and cannabinoid ratios, which influence patient response.
Former commissioner, Deborah Miran, was a member of the Natalie M. LaPrade Maryland Medical Cannabis Commission from 2013- 2016. While serving on the Commission, she was also a member of the executive committee, policy, and research subcommittees, and was chair of the education subcommittee. She was responsible for developing education programs for doctors and patients, and was also an integral part of crafting the current regulations.
Prior to the Commission she was president and founder of Miran Consulting, Inc. There she advised both brand and generic drug makers on the FDA approval process. Ms. Miran was senior director of regulatory affairs for Alpharma, a generic drug manufacturer, where she directed the submission activities for new and abbreviated new drug applications to the FDA. She has spent over 30 years in the US pharmaceutical industry. Ms. Miran received her bachelor of science in chemistry from Iowa State University.
The Cannabusiness Key 2018 Archives
01/05/18 - How Dispensary Employees Can Effectively Assist Medical Cannabis Patients. Video
The Cannabusiness Key 2017 Archives
11/03/17 - Maryland Medical Dispensary Association. Video
10/06/17 - Medical Cannabis Clinical Trials. Video
09/01/17 - Know Before You Borrow: How To Avoid Bad Money And Onerous Loan Obligations In Your Cannabusiness. Video
08/04/17 – Real Estate for Cannabis Businesses. Video
07/14/17 – An Ounce of Prevention is Worth a Pound of Cure Commercial Insurance Preparation. Video
06/02/17 – Takoma Wellness Center: Four Years Dispensing Medical Cannabis 300 ft. across Maryland State Line. Video
05/10/17 – Can Medical Cannabis for Pain Really Help with the Opioid-Dependency Epidemic? Video
04/07/17 – Cannabis Policy and Practice in the Trump Era. Video
03/10/17 – Licensing Considerations for Your Cannabusiness. Video
02/16/17 – Pesticide Issues for Your Cannabusiness. Video
01/13/17 – Security Essentials for Your Cannabusiness. Video